Kenneth Loveday is currently a Distinguished Investigator in Toxicology at Biogen, a position held since 2021. With extensive experience in the field, Kenneth served as a Toxicology Director at Biogen Idec from 2011 and previously held various leadership roles in toxicology at companies such as Acceleron Pharma, Altus Pharmaceuticals, and Transkaryotic Therapies. Kenneth began their academic journey with a PhD in Microbiology from MIT, completed in 1976, which laid the foundation for their distinguished career in toxicology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices